Modeling the burden of cardiovascular disease in Turkey

Objective: This study aims to estimate the current and future burden of cardiovascular diseases (CVD) in Turkey.Methods: A burden-of-disease model was developed that included inputs on population growth, prevalence, and incidence of ischemic disease(IHD) and cerebrovascular disease (CeVD), prevalence of modifiable risk factors, mortality rates, and relationship between risk factors and IHD/CeVD. Direct costs to the public health-care system and indirect costs from lost production due to premature mortality, hospitalizations, disability, and absenteeism were considered.Results: We estimated that in 2016, 3.4 million Turkish adults were living with CVD, including 2.5 million affected by IHD, and 0.9 million by CeVD.This prevalence is projected to increase to 5.4 million by 2035. The economic burden of CVD was estimated at US$10.2 billion in 2016, projectedto increase twofold to US$19.4 billion by 2035.Conclusion: Our study confirms that the current burden of CVD is significant, and that it is projected to increase at a steep rate over the next twodecades. This growing burden of disease will likely create significant pressure on the public health-care system in the form of direct health-carecosts, as well as on society in the form of lost productivity.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. World Health Organization. Cardiovascular Diseases. 2015; Accessed February 22, 2016. http://www.who.int/cardiovascular_diseases/en/.
2. Institute for Health Metrics and Evaluation. GBD Profile: Turkey 2010.
3. Dinç G, Sözmen K, Gerçeklioğlu G, Arık H, Critchley J, Unal B. Decreasing trends in cardiovascular mortality in Turkey between 1988 and 2008. BMC Public Health 2013; 13: 896.
4. World Health Organization. Estimated DALYs ('000) by cause, sex and WHO Member State. Accessed August 30, 2017. http://www.who.int/ healthinfo/global_burden_disease/estimates/en/index2.html.
5. The World Bank. Death rate, crude (per 1,000 people). Accessed August 30, 2017. http://data.worldbank.org/indicator/SP.DYN.CDRT. IN?locations=TR.
6. D'Addato AV, Vignoli V, Yavuz, S. Towards smaller family size in Egypt, Morocco and Turkey: overall change over time or socio-economic compositional effect? Rostock; 2007.
7. Carter S, Taylor D, Kanavos P, Grimaccia F, Tordrup D, Tatar M. Transforming Health in Turkey: 21st Century Opportunities. UCL School of Pharmacy 2012; 1-23.
8. Sozmen K, Unal B. Socioeconomic Inequalities in Non-Communicable Diseases and Self Assessed Health in Turkey. Iran J Public Health 2014; 43: 736-48.
9. Ünal B, Ergör G, Dinç Horasan G, Kalaça, S, Sözmen, K. Chronic Diseases and Risk Factors Survey in Turkey. Ankara: Anıl Matbaa Ltd. Şti 2013; 69-89.
10. Arıcı M, Birdane A, Güler K, Yıldız BO, Altun B, Ertürk S, et al. Turkish Hypertension Consensus Report. Turk Kardiyol Dern Ars 2015; 43: 402-9.
11. Satman I. TURDEP-II Sonuçları. 2011.
12. Institute of Medicine. Promoting Cardiovascular Health in the Developing World: A Critical Challenge to Achieve Global Health: Washington, DC: The National Academies Press; 2010.
13. Checkoway H, Pearce N, Kriebel D. Research Methods in Occupational Epidemiology. Oxford University Press; New York 2004.
14. The World Bank. Health Nutrition and Population Statistics: Population estimates and projections. Accessed July 15, 2016. http:// databank.worldbank.org/data/reports.aspx?source=Health%20Nutrition%20and%20Population%20Statistics:%20Population%20estimates%20and%20projections.
15. Onat A, Senocak MS, Surdum-Avci G, Ornek E. Prevalence of coronary heart disease in Turkish adults. Int J Cardiol 1993; 39: 23-31.
16. Ozturk Y, Demir C, Gursoy K, Koselerli R. Analysis of Stroke Statistics In Turkey. ISPOR 18th Annual European Congress Research Abstracts Research Abstracts 2015; 18: A402.
17. World Health Organization. WHO Mortality Database. Accessed July 15, 2016. 2015; http://www.who.int/healthinfo/mortality_data/en/.
18. Centers for Disease Control and Prevention. Heart Disease. Accessed July 8, 2016. 2016; http://www.cdc.gov/nchs/fastats/heartdisease.htm.
19. Centers for Disease Control and Prevention. Cerebrovascular Disease and Stroke. Accessed July 8, 2016. 2016; http://www.cdc.gov/ nchs/fastats/stroke.htm.
20. Data from the billing system of the University of Health Scienes Türkiye Yüksek Ihtisas Hospital, 2016.
21. Asil T, Celik Y, Sut N, Celik AD, Balci K, Yilmaz A, et al. Cost of acute ischemic and hemorrhagic stroke in Turkey. Clin Neurol Neurosurg 2011; 113: 111-4.
22. Hermus G, Stonebridge C, Dinh T, Didic S, Theriault L. Reducing the Health Care and Societal Costs of Disease: The Role of Pharmaceuticals. The Conference Board of Canada 2013; 105.
23. Gosden TB, Torgerson DJ. Economics notes: Converting international cost effectiveness data to UK prices. BMJ 2002; 325: 275-6.
24. OECD. PPPs and Exchange Rate. Accessed September 18, 2016. 2016; http://stats.oecd.org/Index.aspx?DataSetCode=SNA_TABLE4.
25. Euromonitor International. Euromonitor Country Profile. Accessed August 4, 2016. http://www.euromonitor.com/.
26. The World Bank. World Development Indicators. Accessed September 12, 2016. 2016; http://data.worldbank.org/products/wdi.
27. Sözmen K, Pekel Ö, Yılmaz TS, Şahan C, Ceylan A, Güler E, et al. Determinants of inpatient costs of angina pectoris, myocardial infarction, and heart failure in a university hospital setting in Turkey. Anatol J Cardiol 2015; 15: 325-33.
28. Harbers MM, Achterberg PW. National Institute for Public Health and the Environment. Europeans of retirement age: chronic diseases and economic activity. RIVM, December 2012.
29. The Ministry of Health of Turkey. Turkey Burden of Disease Study. The Ministry of Health of Turkey, editor. Ankara, Turkey 2004.
30. Tasçı C, Özçelik N. An Overview on Coronary Heart Disease (A Comparative Evaluation of Turkey and Europe) and Cost-effectiveness of Diagnostic Strategies. Mol Imaging Radionucl Ther 2011; 20: 75-93.
31. Marinho FM, Soliz P, Gawryszewski V, Gerger A. Epidemiological transition in the Americas: changes and inequalities. The Lancet 2013; 381: S89.
32. World Health Organization. Country Cooperation Strategy At A Glance-Turkey. 2013.
33. Penn State Eberly College of Science. 12.5 - An Extension of Effect Modification - Additive vs Multiplicative Effect Modification. Accessed September 12, 2017. 2017; https://onlinecourses.science.psu. edu/stat507/node/86.
34. Institute for Health Metrics and Evaluation. Turkey Adult Risk Factor Study 2008. Accessed April 19, 2018. 2017; http://ghdx.healthdata.org/ record/turkey-adult-risk-factor-study-2008.

APA	Balbay Y, GAGNON ARPIN I, malhan s, ÖKSÜZ M, SUTHERLAND G, DOBRESCU A, VILLA G, ERTUĞRUL G, HABIB M (2018). Modeling the burden of cardiovascular disease in Turkey. , 235 - 240. 10.14744/AnatolJCardiol.2018.89106
Chicago	Balbay Yucel,GAGNON ARPIN Isabelle,malhan simten,ÖKSÜZ Mehmet ergun,SUTHERLAND Greg,DOBRESCU Alexandru,VILLA Guillermo,ERTUĞRUL Gülnihal,HABIB Mohdhar Modeling the burden of cardiovascular disease in Turkey. (2018): 235 - 240. 10.14744/AnatolJCardiol.2018.89106
MLA	Balbay Yucel,GAGNON ARPIN Isabelle,malhan simten,ÖKSÜZ Mehmet ergun,SUTHERLAND Greg,DOBRESCU Alexandru,VILLA Guillermo,ERTUĞRUL Gülnihal,HABIB Mohdhar Modeling the burden of cardiovascular disease in Turkey. , 2018, ss.235 - 240. 10.14744/AnatolJCardiol.2018.89106
AMA	Balbay Y,GAGNON ARPIN I,malhan s,ÖKSÜZ M,SUTHERLAND G,DOBRESCU A,VILLA G,ERTUĞRUL G,HABIB M Modeling the burden of cardiovascular disease in Turkey. . 2018; 235 - 240. 10.14744/AnatolJCardiol.2018.89106
Vancouver	Balbay Y,GAGNON ARPIN I,malhan s,ÖKSÜZ M,SUTHERLAND G,DOBRESCU A,VILLA G,ERTUĞRUL G,HABIB M Modeling the burden of cardiovascular disease in Turkey. . 2018; 235 - 240. 10.14744/AnatolJCardiol.2018.89106
IEEE	Balbay Y,GAGNON ARPIN I,malhan s,ÖKSÜZ M,SUTHERLAND G,DOBRESCU A,VILLA G,ERTUĞRUL G,HABIB M "Modeling the burden of cardiovascular disease in Turkey." , ss.235 - 240, 2018. 10.14744/AnatolJCardiol.2018.89106
ISNAD	Balbay, Yucel vd. "Modeling the burden of cardiovascular disease in Turkey". (2018), 235-240. https://doi.org/10.14744/AnatolJCardiol.2018.89106

APA	Balbay Y, GAGNON ARPIN I, malhan s, ÖKSÜZ M, SUTHERLAND G, DOBRESCU A, VILLA G, ERTUĞRUL G, HABIB M (2018). Modeling the burden of cardiovascular disease in Turkey. The Anatolian Journal of Cardiology, 20(4), 235 - 240. 10.14744/AnatolJCardiol.2018.89106
Chicago	Balbay Yucel,GAGNON ARPIN Isabelle,malhan simten,ÖKSÜZ Mehmet ergun,SUTHERLAND Greg,DOBRESCU Alexandru,VILLA Guillermo,ERTUĞRUL Gülnihal,HABIB Mohdhar Modeling the burden of cardiovascular disease in Turkey. The Anatolian Journal of Cardiology 20, no.4 (2018): 235 - 240. 10.14744/AnatolJCardiol.2018.89106
MLA	Balbay Yucel,GAGNON ARPIN Isabelle,malhan simten,ÖKSÜZ Mehmet ergun,SUTHERLAND Greg,DOBRESCU Alexandru,VILLA Guillermo,ERTUĞRUL Gülnihal,HABIB Mohdhar Modeling the burden of cardiovascular disease in Turkey. The Anatolian Journal of Cardiology, vol.20, no.4, 2018, ss.235 - 240. 10.14744/AnatolJCardiol.2018.89106
AMA	Balbay Y,GAGNON ARPIN I,malhan s,ÖKSÜZ M,SUTHERLAND G,DOBRESCU A,VILLA G,ERTUĞRUL G,HABIB M Modeling the burden of cardiovascular disease in Turkey. The Anatolian Journal of Cardiology. 2018; 20(4): 235 - 240. 10.14744/AnatolJCardiol.2018.89106
Vancouver	Balbay Y,GAGNON ARPIN I,malhan s,ÖKSÜZ M,SUTHERLAND G,DOBRESCU A,VILLA G,ERTUĞRUL G,HABIB M Modeling the burden of cardiovascular disease in Turkey. The Anatolian Journal of Cardiology. 2018; 20(4): 235 - 240. 10.14744/AnatolJCardiol.2018.89106
IEEE	Balbay Y,GAGNON ARPIN I,malhan s,ÖKSÜZ M,SUTHERLAND G,DOBRESCU A,VILLA G,ERTUĞRUL G,HABIB M "Modeling the burden of cardiovascular disease in Turkey." The Anatolian Journal of Cardiology, 20, ss.235 - 240, 2018. 10.14744/AnatolJCardiol.2018.89106
ISNAD	Balbay, Yucel vd. "Modeling the burden of cardiovascular disease in Turkey". The Anatolian Journal of Cardiology 20/4 (2018), 235-240. https://doi.org/10.14744/AnatolJCardiol.2018.89106